The experience of using this product in pregnant and lactating women is very limited, and the pros and cons should be carefully weighed.
Use in Pregnancy: There are no adequate or well controlled studies in pregnant women. Recomlyse should be given topregnant women only if the potential benefits justify the potential risk to the fetus.
Use in Lactation: It is not known if rhTNK-tPA is excreted into human milk. Caution should be exercised when Recomlyse is administered to a breast-feeding women.
Sign Out